We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.AuthorsDawson SJ; Makretsov N; Blows FM; Driver KE; Provenzano E; Le Quesne J; Baglietto L; Severi G; Giles GG; McLean CA; Callagy G; Green AR; Ellis I; Gelmon K; Turashvili G; Leung S; Aparicio S; Huntsman D; Caldas C; Pharoah PPublicationBritish journal of cancer, 2010, Vol 103, Issue 5, p668ISSN1532-1827Publication typearticleDOI10.1038/sj.bjc.6605736